BiosanaPharma Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 22

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $17M

  • Investors
  • 2

BiosanaPharma General Information

Description

Developer of a biopharmaceutical platform designed to focus on reducing the manufacturing costs of monoclonal antibody biological drugs. The company's platform engages in the development and production of monoclonal antibodies with a focus on biosimilars, enabling medical businesses to reach optimal profitability and improve the lives of patients around the world.

Contact Information

Website
www.biosanapharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Bargelaan 200
  • 2333 CW Leiden
  • Netherlands
+31 06 00000000
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Bargelaan 200
  • 2333 CW Leiden
  • Netherlands
+31 06 00000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BiosanaPharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series C) 03-Dec-2020 $17M 0000 Completed Generating Revenue
4. Later Stage VC 01-Jan-2017 Completed Generating Revenue
3. Early Stage VC (Series B) 01-Dec-2015 Completed Generating Revenue
2. Early Stage VC (Series A) 01-Jan-2015 Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view BiosanaPharma’s complete valuation and funding history, request access »

BiosanaPharma Patents

  • 7

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 6

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

BiosanaPharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20150299644-A1 Discontinuous fed batch processing with the use of alternating bioreactors Active 09-Nov-2012 000000000 0
US-9982226-B2 Discontinuous fed batch processing with the use of alternating bioreactors Active 09-Nov-2012 000000000 00
CA-2890813-A1 Discontinuous fed batch processing with the use of alternating bioreactors Active 09-Nov-2012 000000000
EP-2917323-A1 Discontinuous fed batch processing with the use of alternating bioreactors Pending 09-Nov-2012 000000000
AU-2013341858-A1 Discontinuous fed batch processing with the use of alternating bioreactors Active 09-Nov-2012 C12M47/10
To view BiosanaPharma’s complete patent history, request access »

BiosanaPharma Executive Team (6)

Name Title Board Seat
Ard Tijsterman Co-Founder, Co-Owner, Chief Executive Officer & Board Member
Jaap Engelsman Co-Founder, Chief Financial Officer & Board Member
Menne Zaalberg Chief Operating Officer
Maarten Pennings Chief Technology Officer
Jaap Wieling Ph.D Co-Founder & Chief Scientific Officer
You’re viewing 5 of 6 executive team members. Get the full list »

BiosanaPharma Board Members (7)

Name Representing Role Since
Ard Tijsterman BiosanaPharma Co-Founder, Co-Owner, Chief Executive Officer & Board Member 000 0000
Engelbert Willink MD Ginward Board Member 000 0000
Jaap Engelsman BiosanaPharma Co-Founder, Chief Financial Officer & Board Member 000 0000
Jan Mak Self Board Member 000 0000
Phil Blackshaw Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

BiosanaPharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BiosanaPharma Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Gold Nest Private Capital Venture Capital Minority 000 0000 000000 0
Cicada Innovations Accelerator/Incubator Minority 000 0000 000000 0
To view BiosanaPharma’s complete investors history, request access »

BiosanaPharma Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
BiOraliX 01-Jan-2018 0000000000 Biotechnology
BiOraliX 01-Oct-2017 Joint Venture Biotechnology
To view BiosanaPharma’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial

BiosanaPharma Subsidiaries (1)

Company Name Industry Location Founded
BiOraliX Biotechnology Fochteloo, Netherlands 0000
To view BiosanaPharma’s complete subsidiaries history, request access »

BiosanaPharma FAQs

  • When was BiosanaPharma founded?

    BiosanaPharma was founded in 2012.

  • Who is the founder of BiosanaPharma?

    Ard Tijsterman, Jaap Engelsman, and Jaap Wieling Ph.D are the founders of BiosanaPharma.

  • Who is the CEO of BiosanaPharma?

    Ard Tijsterman is the CEO of BiosanaPharma.

  • Where is BiosanaPharma headquartered?

    BiosanaPharma is headquartered in Leiden, Netherlands.

  • What is the size of BiosanaPharma?

    BiosanaPharma has 22 total employees.

  • What industry is BiosanaPharma in?

    BiosanaPharma’s primary industry is Biotechnology.

  • Is BiosanaPharma a private or public company?

    BiosanaPharma is a Private company.

  • What is BiosanaPharma’s current revenue?

    The current revenue for BiosanaPharma is 000000.

  • How much funding has BiosanaPharma raised over time?

    BiosanaPharma has raised $17M.

  • Who are BiosanaPharma’s investors?

    Gold Nest Private Capital and Cicada Innovations have invested in BiosanaPharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »